Login

William Higgons: "We are acquiring Catana, Sii, and Séché Environnement." 00:10:00

Share On Facebook Share On Twitter

Joël Séché, Président Fondateur de Séché Environnement.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Revolutionizing Surgical Technology: A CEO's Perspective on Advancements and Challenges in the Medtech Industry|Anthony Fernando, CEO, Asensus Surgical Inc .
00:10:00
Inside Loomis Sayles: Balancing Risk and Opportunity with a Multi-Sector Approach
00:10:00
Private Equity's Influence and Future Trends in Capital Markets | Noah Gottdiener, CEO , Duff & Phelps.
00:10:00
PowerTrunk's TETRA Technology Enhances Public Transit Communication and Monitoring.
00:00:00
Clinical practice is with the Internal Medicine Associates / Leigh Simmons, MD
00:10:00
"November 2022 Investment Committee Update with John Shanley, CFP®, and Dan Ballou, CFP® | Connecticut Wealth Management"
00:10:00
Work together to implement value-creating strategies and take companies to the next level|Robert J. Fitzsimmons, Managing Partner,High Road Capital Partners
00:10:00
Building Relationships and Elevating Communication: Insights from Mark Barragan | Estrada Strategies Interview
00:10:00
Addressing Energy Access and Development in Africa: The Role of Renewable Energy and Technological Cooperation
00:10:00
Exploring the Potential of Becoming a Mutual Fund Distributor: Insights from Mr. Faraz
00:10:00
Private Market Valuations and Capital Flows at PE Firms | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
Japan Gold Corp: Leading the Exploration of High-Grade Gold in Japan's Untapped Mineral Riches

© 2026 Nehu